Gossamer Bio (GOSS) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$1.4 billion.
- Gossamer Bio's Retained Earnings fell 1263.91% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year decrease of 1263.91%. This contributed to the annual value of -$1.3 billion for FY2024, which is 466.39% down from last year.
- Per Gossamer Bio's latest filing, its Retained Earnings stood at -$1.4 billion for Q3 2025, which was down 1263.91% from -$1.3 billion recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Retained Earnings registered a high of -$860.6 million during Q1 2022, and its lowest value of -$1.4 billion during Q3 2025.
- Its 4-year average for Retained Earnings is -$1.2 billion, with a median of -$1.2 billion in 2024.
- In the last 5 years, Gossamer Bio's Retained Earnings plummeted by 2565.21% in 2023 and then tumbled by 408.34% in 2025.
- Gossamer Bio's Retained Earnings (Quarter) stood at -$1.0 billion in 2022, then fell by 17.42% to -$1.2 billion in 2023, then decreased by 4.66% to -$1.3 billion in 2024, then fell by 9.71% to -$1.4 billion in 2025.
- Its Retained Earnings was -$1.4 billion in Q3 2025, compared to -$1.3 billion in Q2 2025 and -$1.3 billion in Q1 2025.